Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Ig-Innovations

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ not the name we give the company. Born-out of the acquisition of the diagnostics division of MicroPharm, Ig has captured the skills and expertise developed during the research and development of sheep derived polyclonal antibodies for human therapy (now FDA & MHRA licensed products), diagnostics and research.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Ig-Innovations
Gernos, Maesllyn, Llandysul, SA44 5LP
+44 (0)1239 858972
Contact Ig-Innovations
Website

 Latest Content from PMHub 

Tracking comms trends: communication and market access

White Papers and Resources | June 30, 2016 | Syneos Health®

From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today

Do your customers feel that you’re listening to them?

White Papers and Resources | June 28, 2016 | Anthill Agency

When answering to data, excellent digital communication can create much stronger relationships between reps and customers.

Digital doctors: Talk in 2016

Press Releases | June 27, 2016 | Syneos Health®

The evolving relationship between patient, physician and pharma

How good are your digital sales materials? Just ask these 5 questions

White Papers and Resources | June 15, 2016 | Anthill Agency

Might your sales materials be stuck on step one of the digital technology journey? Consider these five questions to get your answer:

Developing Medical Education That Advances Patient Outcomes

Press Releases | June 15, 2016 | Lucid Group Communications Limited

As pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in...

Biosimilars – the Brexit of the pharmaceutical industry?

White Papers and Resources | June 14, 2016 | Blue Latitude Health

In this article, Senior Consultant Jenna Earl explains what factors influence the uptake of biosimilars in the UK, comparing them to the same principles that help us navigate the complexities...

Future-proofing with a comprehensive talent development strategy

Press Releases | June 10, 2016 | Lucid Group Communications Limited

Lucid Group is an award-winning group of specialist medical education companies. Over the years, Lucid has developed a strong culture of empowerment, thought-leadership, entrepreneurship and passion to improve outcomes for...

“Most eye-catching” agency Pegasus scoops the ‘EMEA Healthcare PR Consultancy of the Year’ at Sabre Awards

Press Releases | June 10, 2016 | Inizio

Pegasus wins the prestigious “EMEA Healthcare PR Consultancy of the Year” award at the recent Sabre Awards in Berlin, organised by The Holmes Report.

Why isn’t your segmentation working?

White Papers and Resources | June 8, 2016 | Blue Latitude Health

How to develop an actionable segmentation for pharma and healthcare marketing that delivers real commercial value.

Digital is different – why new marketing technologies require new ways of working

White Papers and Resources | June 8, 2016 | Anthill Agency

Digital technology: don’t be afraid to demand more